Zhejiang Ruibang Pharmaceutical

Zhejiang Ruibang Pharmaceutical is a prominent Chinese pharmaceutical enterprise focused on the development and production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Based in Wenzhou, the company has established itself as a global leader in the manufacture of Ribavirin, a key antiviral medication used in the treatment of various viral infections. Their product portfolio also features a strong emphasis on immunosuppressants, including Mycophenolate Mofetil and Mycophenolic Acid, which are critical for preventing organ transplantation rejection. The company operates high-standard manufacturing facilities that comply with international GMP requirements and serve a wide range of global pharmaceutical clients. Zhejiang Ruibang's research and development efforts are primarily directed toward nucleoside derivatives and advanced chemical synthesis technologies.